Medicamen Biotech Ltd. Live Share Price Today, Share Analysis and Chart

Name: Medicamen Biotech Ltd.: Is Infosys Ltd. worth buying?
Item: Medicamen Biotech Ltd.
Rating: 2.133458375
Author: Trendlyne DVM scores

Mid-range Performer

about

Medicamen Biotech is engaged in manufacturing of Finished Dosage Forms (FDF).

346.60 -3.95 (-1.13%)

New 52W Low in past week

16,224

NSE+BSE Volume

NSE 04 Sep, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Medium Financial Strength

50.0 / 100

Mid Valuation

34.2 / 100

Technically Neutral

36.5 / 100

Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM

No estimates available

Medicamen Biotech Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Medicamen Biotech Ltd. worth buying?

39 Votes:

Buy 76.92%

Sell 17.95%

Hold 5.13%

Medicamen Biotech Ltd. Live Share Price Today, Share Analysis and Chart

Medicamen Biotech is engaged in manufacturing of Finished Dosage Forms (FDF).

New 52W Low in past week

SWOT Analysis

Medicamen Biotech Live Price Chart